Bristol-myers Squibb Compnay

Rosemount Inc.

James A Johnson

Heather J Finlay

Soong-Hoon Kim

John E Lloyd

Ji Jiang

Zulan Pi

R Michael Lawrence

Jennifer X Qiao

Tammy C Wang

Gregory D Vite

Robert Michael Borzilleri

Richard Louis Nelson

Mark E Salvati

George O Tora

Wu Yang

Yufeng Wang

Lalgudi S Harikrishnan

Eric R Lovegren

Wei Meng

Jacques Y Roberge

Yoon T Jeon

Gregory C Brown

Mark Stephen Schumacher

Joanne M Smallheer

Michael Matthew Miller

Xiaojun Zhang

Bang-Chi Chen

Nicholas Ronald Wurtz

Peter W Glunz

Brian Lee Westfield

Charles G Clark

Robert Paul Brigance

Eldon Scott Priestley

Chad Michael McGuire

Ellen K Kick

James Neels

Naveen Kumar Dhondi

Prashantha Gunaga

Muthoni G Kamau

Michael C Myers

Abhisek Banerjee

Ashokkumar Adisechan

Monique Phillips

Richard A Rampulla

Hannguang J Chao

Garrie David Huisenga

Ningning Xu

Brandon Lee Parkhurst

Robert Michael Weinberger

Donna M Bilder

Randy J Longsdorf

Carol Hui Hu

Vladimir Ladziata

Pravin Sudhakar Shirude

Heidi L Perez

Kurt C Diede

Meriah Neissel Valente

Wen Jiang

Jianqing Li

Greg Edward Gindele

Ryan Thomas Lindsey

Ashok Kumar Adisechan

Andrew Quoc Viet

Amit Kumar Chattopadhyay

Balaji Seshadri

Michael R Lawrence

Jonathon Michael Jongsma

Sunita V Dewnani

Alexander Kover

A wireless field device for use in an industrial process includes input/output terminals configured to couple to a process interface element. A discrete input/output channel is configured to receive a discrete input signal from the process interface element through the input/output terminals when configured as a discrete input channel. The discrete input/output channel is further configured to provide a discrete output to the process interface element through the input/output terminals when configured as discrete output channel. Wireless communication circuitry transmits and receives information. A controller is configured to provide a discrete output signal to the process interface element in response to information received by the wireless communication circuitry when the discrete input/output channel is configured as a discrete output channel, and further configure to receive a discrete input signal from a process variable sensor and responsively provide an output using the wireless communication circuitry when the discrete input/output channel is configured as a discrete input channel. An external power supply input couples to an external power supply. A load adapter module couples to the discrete output signal and the external power supply input and includes a switch configured to connect the process interface element to the external power supply in response to the discrete output signal.

Load adapter module for wireless discrete input/output field device

The disclosure relates to compounds of formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, and related diseases.

Pyrrolidinone derivatives as formyl peptide 2 receptor agonists

A compound of formula I wherein A, X, Y, Z, Rand Rare described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, I-associated disorders, and other disorders mediated by ion channel function.

Quinazolines as potassium ion channel inhibitors

The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists

The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments. 

2,4-dihydroxy-nicotinamides as APJ agonists

4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists

The present invention provides compounds of Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used medicaments. 

Sulfone amide linked benzothiazole inhibitors of endothelial lipase

A wireless field device for use in an industrial process includes input/output terminals configured to couple to a process interface element. A discrete input/output channel is configured to receive a discrete input from the process interface element through the input/output terminals when configured as a discrete input channel. The discrete input/output channel is further configured to provide a discrete output to the process interface element through the input/output terminals when the discrete input/output channel is configured as discrete output channel. Wireless communication circuitry is configured to transmit and receive information. A controller communicates information through the wireless communication circuitry and operates in accordance with configuration information to configure the input/output channel as an input channel when the input/output terminals are connected to a discrete process variable sensor, and further configure the discrete input/output channel as a discrete output channel when the input/output terminals are coupled to a discrete control element.

Wireless field device having discrete input/output

A field device comprises a transducer, a photodetector, a display, and a display controller. The transducer controls or monitors process variable, and the display shows information relating to the process variable. The photodetector detects a light level. The display controller is capable of switching the display on and off in response to changes in the light level detected by the photodetector.

Process device with light change triggered display

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are Factor VIIa inhibitors which may be used as medicaments. 

Macrocyclic factor VIIa inhibitors

Growing community of inventors

Pennington, NJ, United States of America

James A Johnson